A game that went back and forth, it made sense that Friday's baseball game with Westville and Bismarck-Henning went to the last play. The Tigers would score on an fielder's choice hit by Matt Darling ...

Kenai Central High School’s Kyle Foster took the second-place prize, $1,300, for his proposal for a “Moose Mush” fat tire bike and cross-country race series at Tsalteshi Trails and Centennial Park to ...

The Missoula City Council is considering awarding nearly $885,000 in federal housing funds and about $118,000 from the city’s ...

Here is a brief rundown of some coming entertainment options in Northeast Ohio. Make submissions for consideration via email to entertainment@morningjournal.com or entertainment@news-herald.com. You ...

Hiker Rob Cook conquers 100 miles of Pacific Crest Trail, finding freedom from Parkinson's while raising funds for research.

Ore Huiying / Bloomberg / Getty Images Shares of Eli Lilly jumped 16% Thursday morning after the pharmaceutical company released Phase 3 trial results for its oral weight-loss drug that ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes. By Rebecca Robbins and Gina Kolata Encouraging ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

Eli Lilly's stock boomed April 17 after announcing a new experimental pill that caused nearly 8% weight loss at certain dosages and lowered blood sugar in patients during a clinical trial. "We are ...

Injectables for type 2 diabetes and weight loss could soon be a thing of the past. Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small ...

Eli Lilly stock (NYSE: LLY) is gaining momentum on Thursday, April 17th, following the company’s announcement of successful results from the first of its late-stage trials for a daily obesity ...

Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, establishing leadership in obesity treatment. Orforglipron offers advantages ...